Ameriprise’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $940K | Buy |
72,252
+57,152
| +378% | +$744K | ﹤0.01% | 3266 |
|
|
2025
Q1 | $160K | Sell |
15,100
-3,513
| -19% | -$37.2K | ﹤0.01% | 3790 |
|
|
2024
Q4 | $316K | Buy |
18,613
+883
| +5% | +$15K | ﹤0.01% | 3675 |
|
|
2024
Q3 | $412K | Sell |
17,730
-1,460
| -8% | -$33.9K | ﹤0.01% | 3542 |
|
|
2024
Q2 | $467K | Buy |
19,190
+1,305
| +7% | +$31.8K | ﹤0.01% | 3439 |
|
|
2024
Q1 | $604K | Sell |
17,885
-7,343
| -29% | -$248K | ﹤0.01% | 3354 |
|
|
2023
Q4 | $795K | Buy |
25,228
+16,443
| +187% | +$518K | ﹤0.01% | 3286 |
|
|
2023
Q3 | $224K | Sell |
8,785
-138
| -2% | -$3.53K | ﹤0.01% | 3670 |
|
|
2023
Q2 | $256K | Buy |
8,923
+115
| +1% | +$3.3K | ﹤0.01% | 3650 |
|
|
2023
Q1 | $211K | Sell |
8,808
-6,722
| -43% | -$161K | ﹤0.01% | 3713 |
|
|
2022
Q4 | $263K | Buy |
15,530
+1,510
| +11% | +$25.6K | ﹤0.01% | 3632 |
|
|
2022
Q3 | $208K | Buy |
+14,020
| New | +$208K | ﹤0.01% | 3685 |
|
|
2021
Q4 | – | Sell |
-5,830
| Closed | -$279K | – | 3953 |
|
|
2021
Q3 | $279K | Buy |
+5,830
| New | +$279K | ﹤0.01% | 3598 |
|
|
2021
Q1 | – | Sell |
-9,559
| Closed | -$415K | – | 3832 |
|
|
2020
Q4 | $415K | Sell |
9,559
-46,765
| -83% | -$2.03M | ﹤0.01% | 3402 |
|
|
2020
Q3 | $2.42M | Sell |
56,324
-13,978
| -20% | -$600K | ﹤0.01% | 2557 |
|
|
2020
Q2 | $3.29M | Buy |
+70,302
| New | +$3.29M | ﹤0.01% | 2346 |
|